Ninh La-Beck

Texas Tech University Health Sciences Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Warren C. W. Chan

University of Toronto

CANADA

View details

Devin Lowe

Associate Professor

Texas Tech University Health Sciences Center

UNITED STATES

View details

Natalie Serkova

Professor and Vice Chair Research

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

John Maher

King’s College London

UNITED KINGDOM

View details

Agata Exner

Henry Willson Payne Professor

Case Western Reserve University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ninh La-Beck

Research Interests

Explore related searches

Contact this professor

Articles (10)

Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy

Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes.

Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model.

Targeting immune checkpoint pathways in melanoma: triumphs and challenges

Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model.

Antibody-drug conjugates: an evolving approach for melanoma treatment.

Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.

Translational considerations in nanomedicine: The oncology perspective.

Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer

Collaborators (5)

Warren C. W. Chan

Devin Lowe

Natalie Serkova

John Maher

Agata Exner

Make your next move.